{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:52:19Z","timestamp":1792860739045,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s13555-021-00552-6","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T06:02:50Z","timestamp":1623391370000},"page":"1129-1139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1440-5178","authenticated-orcid":false,"given":"Ichiro","family":"Kurokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"552_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.12688\/f1000research.25588.1","volume":"9","author":"I Kurokawa","year":"2020","unstructured":"Kurokawa I, Nakase K. Recent advances in understanding and managing acne. F1000Res. 2020;9:792.","journal-title":"F1000Res"},{"key":"552_CR2","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1600-0625.2009.00890.x","volume":"18","author":"I Kurokawa","year":"2009","unstructured":"Kurokawa I, Kurokawa I, Danby FW, Ju Q. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 2009;18:821\u201332.","journal-title":"Exp Dermatol"},{"issue":"4 Pt 2 Suppl","key":"552_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0190-9622(82)70063-5","volume":"6","author":"GL Peck","year":"1982","unstructured":"Peck GL, Olsen TG, Butkus D, et al. Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study. J Am Acad Dermatol. 1982;6(4 Pt 2 Suppl):735\u201345.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 4","key":"552_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdv.13190","volume":"29","author":"B Dreno","year":"2015","unstructured":"Dreno B, Gollnick HP, Kang S, et al. Understanding innate immunity and inflammation in acne: implications for management. J Eur Acad Dermatol Venereol. 2015;29(Suppl 4):3\u201311.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"552_CR5","first-page":"321","volume":"28","author":"T Jansen","year":"1997","unstructured":"Jansen T, Plewig G. Advances and perspectives in acne therapy. Eur J Med Res. 1997;28(2):321\u201334.","journal-title":"Eur J Med Res"},{"key":"552_CR6","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1365-2133.2009.09531.x","volume":"161","author":"AM Layton","year":"2009","unstructured":"Layton AM, Eady EA. Benzoyl peroxide and adapalene fixed combination: a novel agent for acne. Br J Dermatol. 2009;161:971\u20136.","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"552_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/bjd.13681","volume":"172","author":"V Bettoli","year":"2015","unstructured":"Bettoli V, Zauli S, Virgili A. Is hormonal treatment still an option in acne today? Br J Dermatol. 2015;172(Suppl 1):37\u201346.","journal-title":"Br J Dermatol"},{"key":"552_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-0625.1998.tb00323.x","volume":"7","author":"A Layton","year":"1998","unstructured":"Layton A, Morris C, Cunliffe WJ, Ingham E. Immunohistochemical investigation of evolving inflammation in lesions of acne vulgaris. Exp Dermatol. 1998;7:191\u20137.","journal-title":"Exp Dermatol"},{"key":"552_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1523-1747.2003.12321.x","volume":"121","author":"AH Jeremy","year":"2003","unstructured":"Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121:20\u20137.","journal-title":"J Invest Dermatol"},{"key":"552_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jdermsci.2009.02.015","volume":"55","author":"H Sugisaki","year":"2009","unstructured":"Sugisaki H, Yamanaka K, Kakeda M, et al. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. J Dermatol Sci. 2009;55:47\u201352.","journal-title":"J Dermatol Sci"},{"key":"552_CR11","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1046\/j.1523-1747.2003.12550_6.x","volume":"121","author":"PE Mouser","year":"2003","unstructured":"Mouser PE, Baker BS, Seaton ED, Chu AC. Propionibacterium acnes-reactive T helper-1 cells in the skin of patients with acne vulgaris. J Invest Dermatol. 2003;121:1226\u20138.","journal-title":"J Invest Dermatol"},{"key":"552_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000087011","volume":"211","author":"J Kim","year":"2005","unstructured":"Kim J. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 2005;211:193\u20138.","journal-title":"Dermatology"},{"key":"552_CR13","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/S0002-9440(10)62479-0","volume":"166","author":"J Kang Am","year":"2005","unstructured":"Kang Am J, Pathol Kang S, Cho S, et al. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-\u03baB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol. 2005;166:1691\u20139.","journal-title":"Am J Pathol"},{"issue":"9","key":"552_CR14","doi-asserted-by":"publisher","first-page":"e105238","DOI":"10.1371\/journal.pone.0105238","volume":"25","author":"HL Kelh\u00e4l\u00e4","year":"2014","unstructured":"Kelh\u00e4l\u00e4 HL, Palatsi R, Fyhrquist N, et al. IL-17\/Th17 pathway is activated in acne lesions. PLoS ONE. 2014;25(9):e105238.","journal-title":"PLoS ONE"},{"key":"552_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1365-2133.2004.05749.x","volume":"150","author":"DB Holland","year":"2004","unstructured":"Holland DB, Jeremy AH, Roberts SG, Seukeran DC, Layton AM, Cunliffe WJ. Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. Br J Dermatol. 2004;150:72\u201381.","journal-title":"Br J Dermatol"},{"key":"552_CR16","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/bjd.16680","volume":"179","author":"B Carlavan","year":"2018","unstructured":"Carlavan B, Carlavan I, Bertino B, Rivier M. Atrophic scar formation in patients with acne involves long-acting immune responses with plasma cells and alteration of sebaceous glands. Br J Dermatol. 2018;179:906\u201317.","journal-title":"Br J Dermatol"},{"key":"552_CR17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jaad.2007.05.013","volume":"57","author":"CG Burghart Burkhart","year":"2007","unstructured":"Burghart Burkhart CG, Burkhart CN. Expanding the microcomedone theory and acne therapeutics: Propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug. J Am Acad Dermatol. 2007;57:722\u20134.","journal-title":"J Am Acad Dermatol"},{"key":"552_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/1523-1747.ep12676804","volume":"62","author":"DD Knutson","year":"1974","unstructured":"Knutson DD. Ultrastructural observations in acne vulgaris: the normal sebaceous follicle and acne lesions. J Invest Dermatol. 1974;62:288\u2013307.","journal-title":"J Invest Dermatol"},{"key":"552_CR19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/1523-1747.ep12477026","volume":"91","author":"I Kurokawa","year":"1988","unstructured":"Kurokawa I, Mayer-da-Silva A, Gollnick H, Orfanos CE. Monoclonal antibody labeling for cytokeratins and filaggrin in the human pilosebaceous unit of normal, seborrhoeic and acne skin. J Invest Dermatol. 1988;91:566\u201371.","journal-title":"J Invest Dermatol"},{"key":"552_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2133.1996.tb07609.x","volume":"134","author":"BR Hughes","year":"1996","unstructured":"Hughes BR, Morris C, Cunliffe WJ, Leigh IM. Keratin expression in pilosebaceous epithelia in truncal skin of acne patients. Br J Dermatol. 1996;134:247\u201356.","journal-title":"Br J Dermatol"},{"key":"552_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/1523-1747.ep12329907","volume":"106","author":"R Guy","year":"1996","unstructured":"Guy R, Green MR, Kealey T. Modeling acne in vitro. J Invest Dermatol. 1996;106:176\u201382.","journal-title":"J Invest Dermatol"},{"key":"552_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/jid.1956.115","volume":"27","author":"EJ Van Scotte","year":"1956","unstructured":"Van Scotte EJ, Maccardle RC. Keratinization of the duct of the sebaceous gland and growth cycle of the hair follicle in the histogenesis of acne in human skin. J Invest Dermatol. 1956;27:405\u201329.","journal-title":"J Invest Dermatol"},{"key":"552_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/jdv.15926","volume":"34","author":"F Fantao","year":"2020","unstructured":"Fantao F, von Engelbrechten M, Seilaz C, Sorg O, Saurat JH. Microcomedones in non-lesional acne prone skin: new orientations on comedogenesis and its prevention. J Eur Acad Dermatol Venereol. 2020;34:357\u201364.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"552_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-319-49274-2","volume-title":"Plewig and Kligman\u2019s acne and rosacea","author":"G Plewig","year":"2019","unstructured":"Plewig G, et al. Acne pathogenesis. In: Plewig G, Melnik B, Chen WC, editors. Plewig and Kligman\u2019s acne and rosacea. 4th ed. Berlin: Springer; 2019. p. 45\u201351.","edition":"4"},{"issue":"suppl 1","key":"552_CR25","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1007\/s13555-016-0168-8","volume":"7","author":"M Picardo","year":"2017","unstructured":"Picardo M, Eichenfeld L, Tan J. Acne and rosacea. Dermatol Ther (Heidelb). 2017;7(suppl 1):S43-s52.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"552_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2133.1971.tb07189.x","volume":"85","author":"JA Cotterill","year":"1971","unstructured":"Cotterill JA, Cunliffe WJ, Williamson B. Severity of acne and sebum excretion rate. Br J Dermatol. 1971;85:93\u20134.","journal-title":"Br J Dermatol"},{"issue":"2 Pt 1","key":"552_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0190-9622(86)70025-X","volume":"14","author":"DT Downing","year":"1986","unstructured":"Downing DT, Stewart ME, Wertz PW, Strauss JS. Essential fatty acids and acne. J Am Acad Dermatol. 1986;14(2 Pt 1):221\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"552_CR28","doi-asserted-by":"publisher","first-page":"858176","DOI":"10.1155\/2010\/858176","volume":"2010","author":"M Ottaviani","year":"2010","unstructured":"Ottaviani M, Camera E, Picardo M. Lipid mediators. Mediators Inflamm. 2010;2010:858176. https:\/\/doi.org\/10.1155\/2010\/858176.","journal-title":"Mediators Inflamm"},{"key":"552_CR29","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/j.0022-202X.2005.23682.x","volume":"124","author":"Y Katsuta","year":"2005","unstructured":"Katsuta Y, Iida T, Inomata S, Denda M. Unsaturated fatty acids induce calcium influx into keratinocytes and cause abnormal differentiation of epidermis. J Invest Dermatol. 2005;124:1008\u201313.","journal-title":"J Invest Dermatol"},{"key":"552_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clindermatol.2017.09.006","volume":"36","author":"B Melnik","year":"2018","unstructured":"Melnik B. Acne vulgaris: the metabolic syndrome of the pilosebaceous follicle. Clin Dermatol. 2018;36:29\u201340.","journal-title":"Clin Dermatol"},{"key":"552_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1067\/mjd.2001.113451","volume":"45","author":"CI Jacob","year":"2001","unstructured":"Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol. 2001;45:109\u201317.","journal-title":"J Am Acad Dermatol"},{"key":"552_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/ijms18030606","volume":"18","author":"R Ogawa","year":"2017","unstructured":"Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18:606.","journal-title":"Int J Mol Sci"},{"key":"552_CR33","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/exd.13460","volume":"28","author":"HI Harn","year":"2019","unstructured":"Harn HI, Ogawa R, Hsu CK, Hughes MW, Tang MJ, Chuong CM. The tension biology of wound healing. Exp Dermatol. 2019;28:464\u201371.","journal-title":"Exp Dermatol"},{"key":"552_CR34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s13555-019-00327-0","volume":"9","author":"C Noishiki","year":"2019","unstructured":"Noishiki C, Hayasaka Y, Ogawa R. Sex differences in keloidogenesis: an analysis of 1659 keloid patients in Japan. Dermatol Ther (Heidelb). 2019;9:747\u201354.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"552_CR35","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/jid.2014.71","volume":"134","author":"R Ogawa","year":"2014","unstructured":"Ogawa R, Watanabe A, Naing BT, et al. Associations between keloid severity and single-nucleotide polymorphisms: importance of rs8032158 as a biomarker of keloid severity. J Invest Dermatol. 2014;134:2041\u20133.","journal-title":"J Invest Dermatol"},{"key":"552_CR36","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/iwj.12763","volume":"14","author":"NM Matsumoto","year":"2017","unstructured":"Matsumoto NM, Peng WX, Aoki M, et al. Histological analysis of hyalinised keloidal collagen formation in earlobe keloids over time: collagen hyalinisation starts in the perivascular area. Int Wound J. 2017;14:1088\u201393.","journal-title":"Int Wound J"},{"issue":"Suppl 1","key":"552_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/bjd.13634","volume":"172","author":"DH Suh","year":"2015","unstructured":"Suh DH, Kwon HH. What\u2019s new in the physiopathology of acne? Br J Dermatol. 2015;172(Suppl 1):13\u20139.","journal-title":"Br J Dermatol"},{"key":"552_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00403-018-1856-2","volume":"310","author":"JH Yang","year":"2018","unstructured":"Yang JH, Yon JY, Moon J, Min S, Kwon HH, Suh DH. Expression of inflammatory and fibrogenetic markers in acne hypertrophic scar formation: focusing on role of TGF-\u03b2 and IGF-1R. Arch Dermatol Res. 2018;310:665\u201373.","journal-title":"Arch Dermatol Res"},{"key":"552_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1684\/ejd.2015.2713","volume":"26","author":"M Saint-Jean","year":"2016","unstructured":"Saint-Jean M, Khammari A, Jasson F, Nguyen JM, Dr\u00e9no B. Different cutaneous innate immunity profiles in acne patients with and without atrophic scars. Eur J Dermatol. 2016;26:68\u201374.","journal-title":"Eur J Dermatol"},{"key":"552_CR40","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/bjd.17851","volume":"181","author":"J Moon","year":"2019","unstructured":"Moon J, Yoon JY, Yang JH, Kwon HH, Min S, Suh DH. Atrophic acne scar: a process from altered metabolism of elastic fibres and collagen fibres based on transforming growth factor-\u03b21 signalling. Br J Dermatol. 2019;181:1226\u201337.","journal-title":"Br J Dermatol"},{"key":"552_CR41","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/bjd.18230","volume":"181","author":"S Ramasamy","year":"2019","unstructured":"Ramasamy S, Barnard E, Dawson TL Jr, Li H. The role of the skin microbiota in acne pathophysiology. Br J Dermatol. 2019;181:691\u20139.","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"552_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jdv.15043","volume":"32","author":"B Dr\u00e9no","year":"2018","unstructured":"Dr\u00e9no B, P\u00e9castaings S, Corvec S, Veraldi S, Khammari A, Roques C. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. J Eur Acad Dermatol Venereol. 2018;32(Suppl 2):5\u201314.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"552_CR43","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1099\/ijsem.0.001367","volume":"66","author":"CFP Scholz","year":"2016","unstructured":"Scholz CFP, Kilian M. The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. Int J Syst Evol Microbiol. 2016;66:4422\u201332.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"Suppl 1","key":"552_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s40257-020-00531-1","volume":"21","author":"B Dr\u00e9no","year":"2020","unstructured":"Dr\u00e9no B, Dagnelie MA, Khammari A, Corvec S. The skin microbiome: a new actor in inflammatory acne. Am J Clin Dermatol. 2020;21(Suppl 1):18\u201324.","journal-title":"Am J Clin Dermatol"},{"key":"552_CR45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/jdv.12224","volume":"28","author":"C Beylot","year":"2014","unstructured":"Beylot C, Auffret N, Poli F, et al. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol. 2014;28:271\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"552_CR46","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1365-4632.2003.01588.x","volume":"42","author":"CN Burkhart","year":"2003","unstructured":"Burkhart CN, Burkhart CG. Microbiology\u2019s principle of biofilms as a major factor in the pathogenesis of acne vulgaris. Int J Dermatol. 2003;42:925\u20137.","journal-title":"Int J Dermatol"},{"key":"552_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41429-020-0278-5","volume":"73","author":"K Tabara","year":"2020","unstructured":"Tabara K, Tamura R, Nakamura A, et al. Anti-inflammatory effects of ozenoxacin, a topical quinolone antimicrobial agent. J Antibiot (Tokyo). 2020;73:247\u201354.","journal-title":"J Antibiot (Tokyo)"},{"key":"552_CR48","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619\u201344.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"552_CR49","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/1346-8138.14997","volume":"46","author":"A Morita","year":"2019","unstructured":"Morita A, Takahashi H, Ozawa K, et al. Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa. J Dermatol. 2019;46:745\u201351.","journal-title":"J Dermatol"},{"key":"552_CR50","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/ced.12540","volume":"40","author":"ZZ Yiu","year":"2015","unstructured":"Yiu ZZ, Madan V, Griffiths CE. Acne conglobata and adalimumab: use of tumour necrosis factor-\u03b1 antagonists in treatment-resistant acne conglobata, and review of the literature. Clin Exp Dermatol. 2015;40:383\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"552_CR51","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/1346-8138.14998","volume":"46","author":"T Takahashi","year":"2019","unstructured":"Takahashi T, Yamasaki K, Terui H, et al. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: a case report and review of published cases. J Dermatol. 2019;46:802\u20137.","journal-title":"J Dermatol"},{"key":"552_CR52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/jid.2014.290","volume":"135","author":"M Kistowska","year":"2015","unstructured":"Kistowska M, Meier B, Proust T, et al. Propionibacterium acnes promotes Th17 and Th17\/Th1 responses in acne patients. J Invest Dermatol. 2015;135:110\u20138.","journal-title":"J Invest Dermatol"},{"key":"552_CR53","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/jid.2013.334","volume":"134","author":"GW Agak","year":"2014","unstructured":"Agak GW, Qin M, Nobe J, et al. Propionibacterium acnes induces an IL-17 response in acne vulgaris that is regulated by vitamin A and vitamin D. J Invest Dermatol. 2014;134:366\u201373.","journal-title":"J Invest Dermatol"},{"key":"552_CR54","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/jid.2013.400","volume":"134","author":"DM Thiboutot","year":"2014","unstructured":"Thiboutot DM, Layton AM, Eady AE. IL-17: a key player in the P. acnes inflammatory cascade? J Invest Dermatol. 2014;134:307\u201310.","journal-title":"J Invest Dermatol"},{"key":"552_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jaad.2018.06.046","volume":"80","author":"ARJV Vossen","year":"2019","unstructured":"Vossen ARJV, van Doorn MBA, van der Zee HH, Prens EP. Apremilast for moderate hidradenitis suppurativa: results of a randomized controlled trial. J Am Acad Dermatol. 2019;80:80\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"552_CR56","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/09546634.2017.1395806","volume":"29","author":"M Maarouf","year":"2018","unstructured":"Maarouf M, Clark AK, Lee DE, Shi VY. Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials. J Dermatolog Treat. 2018;29:441\u20139.","journal-title":"J Dermatolog Treat"},{"key":"552_CR57","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","volume":"25","author":"CA Dinarello","year":"2013","unstructured":"Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol. 2013;25:469\u201384.","journal-title":"Semin Immunol"},{"key":"552_CR58","first-page":"1","volume":"25","author":"J Tan","year":"2020","unstructured":"Tan J, Miklas M. A novel topical retinoid for acne: trifarotene 50 \u03bcg\/g Cream. Skin Therapy Lett. 2020;25:1\u20132.","journal-title":"Cream Skin Therapy Lett"},{"key":"552_CR59","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1600-0625.2011.01339.x","volume":"20","author":"T Zuliani","year":"2011","unstructured":"Zuliani T, Khammari A, Chaussy H, Knol AC, Dr\u00e9no B. Ex vivo demonstration of a synergistic effect of adapalene and benzoyl peroxide on inflammatory acne lesions. Exp Dermatol. 2011;20:850\u20133.","journal-title":"Exp Dermatol"},{"key":"552_CR60","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1038\/jid.2012.111","volume":"132","author":"MC Dispenza","year":"2012","unstructured":"Dispenza MC, Wolpert EB, Gilliland KL, et al. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. J Invest Dermatol. 2012;132:2198\u2013205.","journal-title":"J Invest Dermatol"},{"key":"552_CR61","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","volume":"156","author":"A Hebert","year":"2020","unstructured":"Hebert A, Thiboutot D, Stein Gold L, et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials. JAMA Dermatol. 2020;156:621\u201330.","journal-title":"JAMA Dermatol"},{"key":"552_CR62","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jaad.2003.07.021","volume":"50","author":"J Leyden","year":"2004","unstructured":"Leyden J, Bergfeld W, Drake L, et al. A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. J Am Acad Dermatol. 2004;50:443\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"552_CR63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1046\/j.1365-2230.1998.00315.x","volume":"23","author":"C Letawe","year":"1998","unstructured":"Letawe C, Boone M, Pi\u00e9rard GE. Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones. Clin Exp Dermatol. 1998;23:56\u20138.","journal-title":"Clin Exp Dermatol"},{"issue":"Suppl 1","key":"552_CR64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/bjd.13639","volume":"172","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Bettoli V. Management of severe acne. Br J Dermatol. 2015;172(Suppl 1):27\u201333.","journal-title":"Br J Dermatol"},{"key":"552_CR65","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40257-019-00493-z","volume":"21","author":"DH Marks","year":"2020","unstructured":"Marks DH, Prasad S, De Souza B, Burns LJ, Senna MM. Topical antiandrogen therapies for androgenetic alopecia and acne vulgaris. Am J Clin Dermatol. 2020;21:245\u201354.","journal-title":"Am J Clin Dermatol"},{"key":"552_CR66","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00403-019-01908-x","volume":"311","author":"TX Cong","year":"2019","unstructured":"Cong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res. 2019;311:337\u201349.","journal-title":"Arch Dermatol Res"},{"key":"552_CR67","doi-asserted-by":"crossref","first-page":"205951311769093","DOI":"10.1177\/2059513117690937","volume":"3","author":"I Goutos","year":"2017","unstructured":"Goutos I, Ogawa R. Steroid tape: a promising adjunct to scar management. Scars Burn Heal. 2017;3:2059513117690937.","journal-title":"Scars Burn Heal"},{"key":"552_CR68","first-page":"7","volume":"2019","author":"R Ogawa","year":"2018","unstructured":"Ogawa R, Akita S, Akaishi S, et al. Diagnosis and treatment of keloids and hypertrophic scars\u2014Japan Scar Workshop consensus document. Burns Trauma. 2018;2019:7\u201339.","journal-title":"Burns Trauma"},{"key":"552_CR69","first-page":"1","volume":"5","author":"R Ogawa","year":"2019","unstructured":"Ogawa R, Tosa M, Dohi T, Akaishi S, Kuribayashi S. \nSurgical excision and postoperative radiotherapy for keloids. Scars Burn Heal. 2019;5:1\u201311.","journal-title":"Scars Burn Heal"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00552-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-021-00552-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00552-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T04:07:43Z","timestamp":1627618063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-021-00552-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1007\/s13555-021-00552-6","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}